KA
Kozak & Associates Portfolio holdings
AUM
$491M
This Quarter Return
+15.6%
1 Year Return
+18.02%
3 Year Return
+104.79%
5 Year Return
–
10 Year Return
–
AUM
$491M
AUM Growth
+$491M
(+22%)
Cap. Flow
+$14.7M
Cap. Flow
% of AUM
2.99%
Top 10 Holdings %
Top 10 Hldgs %
74.14%
Holding
494
New
35
Increased
156
Reduced
69
Closed
46
Top Buys
| 1 |
iShares US Financial Services ETF
IYG
|
$4.3M |
| 2 |
iShares US Industrials ETF
IYJ
|
$3.45M |
| 3 |
Health Care Select Sector SPDR Fund
XLV
|
$1.9M |
| 4 |
Invesco S&P 500 Revenue ETF
RWL
|
$915K |
| 5 |
Waste Management
WM
|
$889K |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$444K |
| 2 |
DFS
Discover Financial Services
DFS
|
$418K |
| 3 |
SPDR Portfolio S&P 500 Growth ETF
SPYG
|
$273K |
| 4 |
UnitedHealth
UNH
|
$238K |
| 5 |
GE Aerospace
GE
|
$216K |
Sector Composition
| 1 | Technology | 16.41% |
| 2 | Consumer Discretionary | 4.78% |
| 3 | Consumer Staples | 4.4% |
| 4 | Financials | 2.38% |
| 5 | Communication Services | 1.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Intuit
INTU
$185B
| $9.32K | ﹤0.01% |
12
| – | – |
|
252
Boston Beer
SAM
$2.35B
| $9.31K | ﹤0.01% |
48
| – | – |
|
253
Freeport-McMoran
FCX
$64.5B
| $9.15K | ﹤0.01% |
201
-79
| -28% | -$3.6K |
|
254
First Trust US Equity Opportunities ETF
FPX
$1.02B
| $9.06K | ﹤0.01% |
63
| – | – |
|
255
Bath & Body Works
BBWI
$6.26B
| $9.03K | ﹤0.01% |
274
+2
| +0.7% | +$66 |
|
256
Nuveen Real Estate Income Fund
JRS
$232M
| $9.03K | ﹤0.01% |
+1,157
| New | +$9.03K |
|
257
BP
BP
$90.8B
| $8.98K | ﹤0.01% |
287
+4
| +1% | +$125 |
|
258
Sabesp
SBS
$15.1B
| $8.8K | ﹤0.01% |
427
| – | – |
|
259
Carnival Corp
CCL
$42.2B
| $8.65K | ﹤0.01% |
300
| – | – |
|
260
Keurig Dr Pepper
KDP
$39.3B
| $8.36K | ﹤0.01% |
248
| – | – |
|
261
Axcelis
ACLS
$2.5B
| $7.96K | ﹤0.01% |
+107
| New | +$7.96K |
|
262
HCA Healthcare
HCA
$95B
| $7.69K | ﹤0.01% |
20
| – | – |
|
263
Invesco BuyBack Achievers ETF
PKW
$1.45B
| $7.5K | ﹤0.01% |
60
+1
| +2% | +$125 |
|
264
Palo Alto Networks
PANW
$127B
| $7.42K | ﹤0.01% |
36
| – | – |
|
265
RH
RH
$4.15B
| $7.11K | ﹤0.01% |
35
| – | – |
|
266
Arch Capital
ACGL
$34.1B
| $6.95K | ﹤0.01% |
79
| – | – |
|
267
3M
MMM
$82.2B
| $6.94K | ﹤0.01% |
45
+1
| +2% | +$154 |
|
268
Prologis
PLD
$103B
| $6.67K | ﹤0.01% |
63
-55
| -47% | -$5.82K |
|
269
Victory Capital Holdings
VCTR
$4.74B
| $6.61K | ﹤0.01% |
102
| – | – |
|
270
Bristol-Myers Squibb
BMY
$96.5B
| $6.58K | ﹤0.01% |
138
+2
| +1% | +$95 |
|
271
Rambus
RMBS
$7.91B
| $6.48K | ﹤0.01% |
+100
| New | +$6.48K |
|
272
United Therapeutics
UTHR
$18.3B
| $6.31K | ﹤0.01% |
21
| – | – |
|
273
Ford
F
$46.6B
| $6.27K | ﹤0.01% |
530
-393
| -43% | -$4.65K |
|
274
Vertex Pharmaceuticals
VRTX
$103B
| $6.23K | ﹤0.01% |
13
| – | – |
|
275
Pultegroup
PHM
$26.1B
| $6.2K | ﹤0.01% |
55
+1
| +2% | +$113 |
|